• by Fern Siegel , Yesterday

Brooklyn agency The BAM Connection has added to its Rohto portfolio.

After launching Rohto’s Dual Light Relief product in 2024, the agency is now responsible for all Rohto Eyedrops in the U.S. That includes the Max Strength, Cool Relief, and Optic Glow products. 

BAM will handle strategy, social, media and partnership opportunities. New work is expected in July.

“What an opportunity for our agency to take on the full suite of products,” said Maureen Maldari, The BAM CEO.

Jim Thornton, head of sales, U.S. domestic, The Mentholatum Company, added: “BAM has proven to be a true partner. They keep showing up with ideas we love.” 

Rohto has relieved health issues — red, dry, irritated eyes — for customers for more than 115 years. Rohto Pharmaceutical, the parent company of Rohto Eye Drops, reported $1.85 billion in 2023 revenue.

Founded in 2013, the BAM Connection counts Birds Eye, Parrot Bay and KCR among its client work.